10-K: Yijia Group Corp. Reports Significant Revenue Growth in Fiscal Year 2024 Driven by Healthcare Segment

Yijia Group Corp. experienced a substantial increase in revenue during fiscal year 2024, primarily due to the expansion of its healthcare product sales.

Summary

• Yijia Group Corp. reported a significant increase in revenue, reaching $570,694 in fiscal year 2024, compared to $38,000 in the previous year.
• This growth was largely driven by the healthcare segment, which generated $544,594 in revenue from the sale of healthcare products.
• The company's consulting service segment contributed $26,100 in revenue.
• The company achieved a gross profit of $377,711, a substantial increase from $38,000 in the prior year.
• Yijia Group Corp. reported a net income of $140,865 for the fiscal year 2024, a significant turnaround from a net loss of $24,227 in 2023.
• The company's operating expenses totaled $172,082, which included sales and distribution, personnel, and general and administrative costs.
• The company raised $957,051 through a private offering of common stock, issuing 19,141,020 shares at $0.05 per share.
• As of April 30, 2024, the company had total current assets of $1,192,858, including $593,036 in cash and $132,873 in inventories.

Sentiment

Score: 7

Explanation: The document shows strong revenue growth and a positive net income, but there are significant concerns about internal controls and risk management. The company is in a high-growth phase but needs to address its operational weaknesses.

Positives

• The company experienced a substantial increase in revenue, primarily driven by the healthcare segment.
• Yijia Group Corp. achieved a net profit of $140,865, a significant improvement from the previous year's loss.
• The company successfully raised $957,051 through a private offering, strengthening its financial position.
• The company has a strong cash position of $593,036 as of April 30, 2024.
• The company has expanded its operations into the healthcare product market with the establishment of Nutripeak Trading Corporation.

Negatives

• The company's disclosure controls and procedures were deemed ineffective as of April 30, 2024.
• The company identified material weaknesses in its internal control over financial reporting, including a lack of an audit committee, inadequate cash controls, and insufficient information technology controls.
• The company does not maintain insurance, which could pose a risk in the event of litigation.
• The company has a limited operating history and is in a start-up phase, which carries inherent risks.
• The company has a small number of employees, with only one full-time employee other than the officers.

Risks

• The company faces intense market competition and must focus on product innovation and development.
• The company's lack of insurance coverage could lead to significant financial losses in the event of litigation.
• The company's cybersecurity measures are in the developmental stage, leaving it vulnerable to cyberattacks and data breaches.
• The company's limited operating history and dependence on key personnel pose risks to its future success.
• The company's internal control weaknesses could lead to material misstatements in its financial statements.

Future Outlook

The company is looking for opportunities to increase profits in 2024 and will continue to assess and update its cybersecurity measures in response to emerging threats.

Management Comments

• Management believes that an audit committee, including a financial expert member, is an utmost important entity level control over the company's financial statement.
• Management has determined that enough uncertainty exists relative to the realization of the deferred income tax asset balances to warrant the application of a full valuation allowance as of April 30, 2024 and 2023.

Industry Context

The company's expansion into the healthcare product market aligns with the growing demand for anti-aging and wellness products. The company's multi-channel sales approach, including e-commerce, its own website, brick-and-mortar stores, social media, and direct sales, is a common strategy in the consumer goods industry.

Comparison to Industry Standards

• Yijia Group Corp.'s revenue growth of 1,402% is significantly higher than the average growth rate in the consulting and healthcare product industries, which typically see single to double-digit growth.
• The company's gross profit margin of approximately 66% is relatively high compared to the average gross profit margin in the healthcare product industry, which is typically between 30% and 50%.
• The company's net income margin of approximately 25% is also relatively high compared to the average net income margin in the healthcare product industry, which is typically between 5% and 15%.
• However, the company's lack of insurance and weak internal controls are significant deviations from industry best practices, particularly for publicly traded companies.
• Compared to companies like GNC or Vitamin Shoppe, Yijia is in a very early stage of development and lacks the established infrastructure and brand recognition of these larger players.

Management Changes

Corporate Governance

Legal Proceedings

• The company is not involved in any material, existing, or pending legal proceedings.

Related Party Transactions

• The company has been provided free office space by its stockholder.
• The company's directors have advanced funds to the company for working capital purposes.
• The company has engaged Triangle Accounting Inc., an entity controlled by Steve Niu, for professional services.

Stakeholder Impact

• Shareholders will benefit from the company's improved financial performance and increased revenue.
• Employees may see potential for growth and development as the company expands.
• Customers will have access to a wider range of healthcare products and services.
• Suppliers will benefit from increased orders and business opportunities.
• Creditors will have increased confidence in the company's ability to meet its obligations.

Next Steps

• The company will evaluate its cybersecurity needs and develop appropriate measures to enhance its cybersecurity posture.
• The company will consider engaging external cybersecurity experts to advise on best practices.
• The company will conduct vulnerability assessments and develop an incident response strategy.
• The company will establish a cybersecurity framework that is commensurate with its size and complexity.
• The company will continue to look for other opportunities which could potentially increase the profits of the Company in the year 2024.

Key Dates

Keywords

healthcare products, consulting services, revenue growth, financial results, internal controls, private placement, net income, cybersecurity, risk factors, financial reporting